Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07585396

Inositol in Letrozol Resistant PCOS Women

Conditions: Polycystic Ovary Syndrome, Infertility

Sex: Female
Ages: 18 Years – 35 Years
Healthy volunteers: No
Phase: PHASE2, PHASE3
Enrollment: 36
Sponsor: Kafrelsheikh University

Location: Kafrelshiekh university hospital Cairo

Summary

Polycystic ovary syndrome (PCOS),is a complex neuro-endocrine disorder affecting approximately 5% to 10% of women in reproductive age.Inositols are considered insulin sensitizers, as they modulate the members of insulin signaling pathways.Thiss study compares between the effect of inositol and metformin in letrozol resistant PCOS women.

Eligibility Criteria

Inclusion Criteria: * • Age between 18- 35 years old. * Diagnosis of PCOS according to Rotterdam criteria * Letrozole resistant cases. * Normal thyroid hormone level. * Normal prolactin hormone level. Exclusion Criteria: * • History of ovarian surgery. * cases associated with endometriosis. * History of diabetes mellitus. * Allergy to myo-Inositol .

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07585396). StuddyBuddy aggregates publicly available trial information.